Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Enpath CE-marks sheath:

This article was originally published in Clinica

Executive Summary

Paving the way for a launch into the European electrophysiology (EP) market, Enpath Medical has CE-marked its steerable sheath, which is designed to facilitate the placement of interventional devices in the peripheral, coronary and neurovascular systems. The product features distal tip deflection to aid in the precise placement of such devices as cardiac ablation catheters and peripheral stent delivery catheters, said the Plymouth, Minnesota firm. It is being launched in Europe for EP applications by Enpath's distribution partner Bard Electrophysiology, a division of CR Bard. The device was cleared in the US in July 2005.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050640

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel